No Data
No Data
Glenview Capital Adds Microsoft, Exits Marvell, Seagate, Others
Is Myriad Genetics (NASDAQ:MYGN) A Risky Investment?
Craig-Hallum Initiates Coverage On Myriad Genetics With Buy Rating, Announces Price Target of $29
Craig-Hallum Initiates Myriad Genetics(MYGN.US) With Buy Rating, Announces Target Price $29
MYGN Stock Might Rise on Collaboration With CancerCARE
Myriad Genetics Management to Meet With BTIG